1. Home
  2. TVTX vs NATL Comparison

TVTX vs NATL Comparison

Compare TVTX & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$38.55

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$38.94

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
NATL
Founded
2008
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TVTX
NATL
Price
$38.55
$38.94
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
$37.21
$42.75
AVG Volume (30 Days)
1.8M
402.3K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.74
Revenue
$435,826,000.00
$4,322,000,000.00
Revenue This Year
$120.02
$2.83
Revenue Next Year
$37.00
$3.96
P/E Ratio
N/A
$22.41
Revenue Growth
114.22
0.63
52 Week Low
$12.91
$22.30
52 Week High
$42.13
$42.23

Technical Indicators

Market Signals
Indicator
TVTX
NATL
Relative Strength Index (RSI) 62.35 61.24
Support Level $33.49 $38.41
Resistance Level $42.13 $39.49
Average True Range (ATR) 1.90 0.80
MACD 0.37 0.05
Stochastic Oscillator 62.18 82.55

Price Performance

Historical Comparison
TVTX
NATL

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

Share on Social Networks: